Vivos Therapeutics, Inc. (VVOS) — Financial ratios
Profitability, liquidity, leverage, and valuation ratios for Vivos Therapeutics, Inc., with annual and quarterly history.
| Metric | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 |
|---|---|---|---|---|---|---|
| Valuation | ||||||
| P/E Ratio | -0.98x | -1.93x | -1.12x | -0.39x | -2.35x | -8.93x |
| P/B Ratio | -14.00x | 2.71x | 36.91x | 1.93x | 1.87x | 6.36x |
| P/S Ratio | 1.20x | 1.43x | 1.10x | 0.58x | 2.83x | 8.24x |
| Profitability | ||||||
| Gross Margin | 60.4% | 60.0% | 59.9% | 62.5% | 74.6% | 79.7% |
| Operating Margin | -114.1% | -74.3% | -125.3% | -156.2% | -115.3% | -92.1% |
| Net Margin | -121.7% | -74.1% | -98.4% | -148.8% | -120.2% | -92.3% |
| EBITDA Margin | -106.5% | -70.5% | -120.8% | -152.0% | -115.7% | -86.0% |
| Liquidity | ||||||
| Current Ratio | 0.24x | 1.50x | 0.34x | 0.80x | 3.64x | 2.61x |
| Quick Ratio | 0.24x | 1.50x | 0.34x | 0.80x | 3.64x | 2.61x |
| Leverage | ||||||
| Debt/Equity | -9.06x | 0.19x | 4.85x | 0.50x | 0.06x | 0.08x |
YoY = year-over-year change. Source: FMP..